日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies

CAR-37 T 细胞治疗复发或难治性 CD37+ 淋巴瘤患者的 I 期研究

Frigault, Matthew J; Graham, Charlotte E; Berger, Trisha R; Ritchey, Julie; Horick, Nora K; El-Jawahri, Areej; Scarfò, Irene; Schmidts, Andrea; Haradhvala, Nicholas J; Wehrli, Marc; Lee, Won-Ho; Parker, Aiyana L; Wiggin, Hadley R; Bouffard, Amanda; Dey, Aonkon; Leick, Mark B; Katsis, Katelin; Elder, Eva L; Dolaher, Maria A; Cook, Daniella T; Chekmasova, Alena A; Huang, Lu; Nikiforow, Sarah; Daley, Heather; Ritz, Jerome; Armant, Myriam; Preffer, Fred; DiPersio, John F; Nardi, Valentina; Chen, Yi-Bin; Gallagher, Kathleen M E; Maus, Marcela V

Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients.

可溶性 CD163 是活化巨噬细胞的一种新型标志物,在 HIV 感染患者中升高,并与非钙化冠状动脉斑块相关

Burdo Tricia H, Lo Janet, Abbara Suhny, Wei Jeffrey, DeLelys Michelle E, Preffer Fred, Rosenberg Eric S, Williams Kenneth C, Grinspoon Steven